FY2025 · ended Dec 31, 2025 · Revenue $2.23B, -6.3% YoY · Filed Feb 19, 2026
Icu Medical INC/DE (ICUI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.2 billion and net income of $732,000. Free cash flow was $91.8 million. As of Jun 30, 2026 it held $298.3 million in cash and investments and $1.3 billion in total debt.
Revenue (TTM)
$2.16B
-9.0% vs year-ago TTM
Net income
$732,000
+100.6% vs prior year
Operating cash flow (TTM)
$236.37M
+70.3% vs year-ago TTM
Free cash flow (TTM)
$152.83M
+152.5% vs year-ago TTM
EPS
$0.03
+100.6% vs prior year
Dividend per share
None
Shares outstanding
24.69M
+0.7% vs prior year
Net cash
$-988.85M
as of Jun 30, 2026
Operating margin
3.3%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ICUI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Clemente, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 883984
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.4B | $2.3B | $2.3B | $1.3B |
| Operating income | $42.8M | $43.0M | $22.8M | -$42.9M | $123.2M |
| Net income | $732,000 | -$117.7M | -$29.7M | -$74.3M | $103.1M |
| Diluted EPS | $0.03 | -$4.83 | -$1.23 | -$3.11 | $4.74 |
| Operating cash flow | $179.8M | $204.0M | $166.2M | -$62.1M | $267.5M |
| Free cash flow | $91.8M | $124.7M | $82.3M | -$152.4M | $199.0M |
| Total assets | $4.1B | $4.2B | $4.4B | $4.5B | $1.9B |
| Stockholders' equity | $2.1B | $2.0B | $2.1B | $2.1B | $1.6B |
| Cash and investments | $308.0M | $308.6M | $254.7M | $213.5M | $571.9M |
| Total debt | $1.3B | $1.6B | $1.7B | $1.7B | $45.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 18, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 2, 2026 | Dec 31, 2025 |
All 1000 Icu Medical INC/DE SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.